scholarly journals Introducing Long-Acting Contraceptive Removal Indicators in a Pilot Study in Mozambique: Dynamics of Discontinuation and Implications for Quality of Care

2022 ◽  
Author(s):  
Ana Jacinto ◽  
Adalgisa Viola Ronda ◽  
Connie Lee ◽  
Fariyal F. Fikree ◽  
Eric Ramirez-Ferrero
Keyword(s):  
Quality Of Care ◽  
Pilot Study ◽  
Long Acting

Prescriptions Ordered by Podiatrists for Ambulatory Patients

1978 ◽  
Vol 12 (12) ◽  
pp. 720-727
Author(s):  
T. Donald Rucker ◽  
Leonard Janis ◽  
Marialice Bennett
Keyword(s):  
Quality Of Care ◽  
Pilot Study ◽  
Dosage Form ◽  
Oral Dosage ◽  
Survey Period ◽  
Oral Dosage Form ◽  
Ambulatory Patients

This pilot study describes and suggests quality of care considerations related to prescriptions ordered by podiatrists for ambulatory patients. During the four-month survey period, the average podiatrist initiated 120 prescription orders and utilized 26 different drug entities. The 44 practitioners employed 235 different preparations, headed by Lotrimin®, Mepergan Fortis® and erythromycin. Although refill orders were judged as conservative, questions are raised about the use of oral dosage form combination products, agents employed infrequently, and the desired therapeutic intention of some preparations.

scholarly journals Current Use of Intravenous (IV) Long Acting Antibiotic (LAA) Therapy in the Aetna Health Plan among Patients with Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

2017 ◽  
Vol 4 (suppl_1) ◽  
pp. S339-S340
Author(s):  
Rajesh Mehta ◽  
Alison Edwards ◽  
Katelyn R Keyloun ◽  
Nicole Bonine ◽  
Iver Juster
Keyword(s):  
Sensitivity Analysis ◽  
Quality Of Care ◽  
Cost Savings ◽  
Potential Cost ◽  
Treatment Pathways ◽  
Inpatient Management ◽  
Inpatient Population ◽  
Long Acting ◽  
Potential Opportunity

Abstract Background In an effort to lower costs and improve quality of care, there is potential to change the treatment landscape for low-risk (i.e., less severe) ABSSSI patients who historically required inpatient management, a costly option. Outpatient IV treatment pathways have been shown to be a cost-saving option for hospitals and insurers. The objective was to quantify the potential opportunity for reducing cost of ABSSSI treatment in an insured Commercial and Medicare Aetna population. Methods Adult patients between January 2013 and July 2016 were identified with a primary ABSSSI claim (Table 1) in the Aetna fully-insured Commercial and Medicare insurance claims database. ABSSSI encounters were identified with insurance eligibility for the 7 months prior to and no evidence of ABSSSI in the 30 days prior to the ABSSSI claim. Demographic and clinical data were described, including length of stay (LOS) and allowed cost for inpatient encounters with data. Inpatient encounters without evidence of severity (e.g., codes for major complications or comorbidities) were considered potential candidates for an outpatient LAA pathway. A sensitivity analysis for LOS and cost was run including all ABSSSI patients with LAA dispenses through 2016 (i.e., inclusion/exclusion criteria did not need to be met). Results 194,023 ABSSSI encounters were identified, most receiving non-IV treatment (90%). 18,603 received IV treatment, where 83% initially presented to the emergency room and the majority were admitted (97%). Of the 28 encounters with LAA use, 7 were inpatient. Of all current inpatient encounters (N = 9,019 after Jan 1, 2015), the majority (N = 7,005; 78%) where considered potential LAA pathway candidates. Comparing inpatient encounters with vs. without LAA use, mean LOS and cost differed (Table 2: 4.1 days and $14,295 vs. 9.0 days and $23,194, respectively). A sensitivity analysis supported similar mean LOS and cost for all inpatient LAA dispenses. Conclusion Current use of LAA in an inpatient population is limited but resulted in potential cost-savings. Most of the inpatient population was identified as potential candidates for an outpatient LAA pathway. Research on utilization and quality of care for outpatient IV treatment pathways with LAA is warranted. Disclosures K. R. Keyloun, Allergan: Employee, Salary N. Bonine, Allergan: Employee, Salary

scholarly journals A Pilot Study of Staff Nursesʼ Perceptions of Factors That Influence Quality of Care in Critical Access Hospitals

2013 ◽  
Vol 28 (4) ◽  
pp. 352-359 ◽  
Author(s):  
Marianne Baernholdt ◽  
Bonnie Mowinski Jennings ◽  
Erica Jeané Lewis
Keyword(s):  
Quality Of Care ◽  
Pilot Study ◽  
Critical Access Hospitals

A pilot study of satisfaction in oncology nursing care: an indirect predictor of quality of care

2012 ◽  
Vol 25 (2) ◽  
pp. 106-117 ◽  
Author(s):  
Esther Uña Cidón ◽  
Fernando Cuadrillero Martín ◽  
Milagros Hijas Villaizán ◽  
Francisco López Lara
Keyword(s):  
Quality Of Care ◽  
Pilot Study ◽  
Nursing Care ◽  
Oncology Nursing

Quality of Care Measurement in Nursing Home AIDS Care: A Pilot Study

2002 ◽  
Vol 13 (2) ◽  
pp. 70-76 ◽  
Author(s):  
Jinah K. Shin ◽  
Laurie S. Newman ◽  
Kristine M. Gebbie ◽  
Herbert H. Fillmore
Keyword(s):  
Nursing Home ◽  
Quality Of Care ◽  
Pilot Study

Real-life pilot study on the impact of the telemedicine platform EasyMICI–MaMICI® on quality of life and quality of care in patients with inflammatory bowel disease

2021 ◽  
pp. 1-7
Author(s):  
Guillaume Bonnaud ◽  
Audrey Haennig ◽  
Romain Altwegg ◽  
Bénédicte Caron ◽  
Lucile Boivineau ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Inflammatory Bowel Disease ◽  
Quality Of Care ◽  
Pilot Study ◽  
Bowel Disease ◽  
Real Life ◽  
Inflammatory Bowel ◽  
The Impact

scholarly journals P587 Quality of care indicators in inflammatory bowel disease: local pilot study

2019 ◽  
Vol 13 (Supplement_1) ◽  
pp. S408-S408
Author(s):  
R Sarraj ◽  
F Bravo ◽  
M Maude ◽  
A Macpherson ◽  
P Juillerat
Keyword(s):  
Inflammatory Bowel Disease ◽  
Quality Of Care ◽  
Pilot Study ◽  
Bowel Disease ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document